Study on Effect of Ginkgo Ketone on Inlfammatory Response and Cognitive Function in Patients with Acute Ischemic Stroke
Hong-Yu CHENG,Xin-Jiang ZHANG,Shan-Shan LI,Bin LIU,Yuan SHAO,Yun XU,Mei-Juan ZHANG
DOI: https://doi.org/10.3969/j.issn.1673-5765.2016.11.009
2016-01-01
Abstract:Objective To investigate the effect of Ginkgo ketone ester dispersible tablets on the inlfammatory reaction and cognitive function after ischemic stroke and its clinical signiifcance. <br> Methods This study was a prospective, multi-center, clinical randomized and controlled trial. Patients with acute ischemic stroke from Neurological Department in Nanjing Drum Tower Hospital and Yangzhou First People's Hospital during October 2012 to June 2014 were recruited and randomly divided into therapeutic group (Ginkgo ketone ester dispersible tablets (0.15 tid) combined with aspirin group (0.1 qd) and control group (aspirin group (0.1 qd), medication 180 d). Fresh blood was harvested before treatment and 13±1 days after treatment from enrolled patients. Serum inlfammatory cytokines (IL-1β, IL-6, IL-15, IL-17A, IL-23 and TNF-α) were detected by Milliplex Map multiple detection techniques. National Institutes Health Stroke Scale (NIHSS), modiifed Rankin Scale (mRS), Mini-Metal State Examination (MMSE) and Montreal Cognitive Assessment (MOCA) were applied to evaluate neurological deifcits and cognitive decline before treatment and (13±1) d, (30±7) d, (90±7) d, (180±7) d after treatment, and to compare scale scores changes in two groups before and after treatment. <br> Results A total of 60 patients were enrolled into study. Among whom, 8 cases were excluded due to non-eligible blood specimen; 27 cases of study group and 25 cases of control group were taken into statistical analysis. Treatment of (13±1) d, the serum IL-1 beta IL-1β ([1.55±0.43] pg/mlvs [2.05±0.74] pg/ml,P<0.001), IL-15 ([1.88±0.82] pg/mlvs [3.17±1.93] pg/ml,P<0.001), IL-6 ([5.57±4.96] pg/mlvs [8.81±8.00] pg/ml,P=0.042), IL-17A ([5.11±1.51] pg/mlvs [6.67±2.24] pg/ml,P<0.001), IL-23 ([0.42±0.88] pg/mlvs [0.67±0.98] pg/ml,P<0.001), TNF-alpha ([15.12±6.97] pg/mlvs [18.31±6.61] pg/ml,P=0.009) levels in therapeutic group were decreased significantly than that before treatment; while in the control group, only IL-15 ([2.01±0.72] pg/mlvs [2.53±1.20] pg/ml,P=0.036) level was signiifcantly decreased compared with that of before treatment. After treatment (30±7) d, (90±7) d, (180±7) d in the therapeutic group, MMSE and MOCA scores were improved more signiifcantly than that before treatment compared with the control group (P=0.036, 0.012 and 0.048), though the two scores were of no signiifcant differences in two groups. <br> Conclusion The combination of Ginkgo ketone ester dispersible tablets and aspirin can more obviously reduce serum inlfammatory cytokines and improve their cognitive function compared with using aspirin alone in ischemic stroke patient.